Themis Medicare Limited Market Cap ($99.33 Million)
Market Cap & Net Worth: Themis Medicare Limited (THEMISMED)
Themis Medicare Limited market cap. Themis Medicare Limited (NSE:THEMISMED) has a market capitalization of $99.33 Million (Rs9.19 Billion) as of November 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #19029 globally and #1039 in its home market, demonstrating a 9.15% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Themis Medicare Limited's stock price Rs99.73 by its total outstanding shares 92100120 (92.10 Million). Also see Themis Medicare Limited cash conversion from operations for how efficiently the company converts equity into cash flow.
Themis Medicare Limited Market Cap History (2015–2026)
Themis Medicare Limited market cap history from 2015 to 2026. Data shows growth from $43.60 Million to $99.33 Million (12.63% CAGR). Check latest Themis Medicare Limited stock price today for real-time trading data and today's change.
Themis Medicare Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Themis Medicare Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Themis Medicare Limited growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.03x
Themis Medicare Limited's market cap is 0.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
8.68x
Themis Medicare Limited's market cap is 8.68 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $52.05 Million | $2.46 Billion | $194.90 Million | 0.02x | 0.27x |
| 2018 | $29.60 Million | $2.10 Billion | $112.97 Million | 0.01x | 0.26x |
| 2019 | $28.18 Million | $1.84 Billion | -$107.42 Million | 0.02x | N/A |
| 2020 | $32.29 Million | $2.02 Billion | $247.82 Million | 0.02x | 0.13x |
| 2021 | $84.55 Million | $2.31 Billion | $357.03 Million | 0.04x | 0.24x |
| 2022 | $130.02 Million | $3.95 Billion | $728.81 Million | 0.03x | 0.18x |
| 2023 | $212.39 Million | $3.54 Billion | $569.01 Million | 0.06x | 0.37x |
| 2024 | $262.50 Million | $3.82 Billion | $435.24 Million | 0.07x | 0.60x |
| 2025 | $100.20 Million | $4.06 Billion | $298.33 Million | 0.02x | 0.34x |
| 2026 | $99.33 Million | $3.42 Billion | $11.44 Million | 0.03x | 8.68x |
Competitor Companies of THEMISMED by Market Capitalization
Companies near Themis Medicare Limited in the global market cap rankings as of November 4, 2026. Also see balance sheet size of Themis Medicare Limited for a full breakdown of the balance sheet.
Key companies related to Themis Medicare Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Themis Medicare Limited (2015–2026)
Market capitalization of Themis Medicare Limited from 2015 to today. Between 2015 and today, Themis Medicare Limited's market cap moved from $43.60 Million to $ 99.33 Million, with a yearly change of 12.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs99.33 Million | -0.86% |
| 2025 | Rs100.20 Million | -61.83% |
| 2024 | Rs262.50 Million | +23.60% |
| 2023 | Rs212.39 Million | +63.36% |
| 2022 | Rs130.02 Million | +53.78% |
| 2021 | Rs84.55 Million | +161.83% |
| 2020 | Rs32.29 Million | +14.61% |
| 2019 | Rs28.18 Million | -4.82% |
| 2018 | Rs29.60 Million | -43.12% |
| 2017 | Rs52.05 Million | +5.31% |
| 2016 | Rs49.42 Million | +13.35% |
| 2015 | Rs43.60 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Themis Medicare Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $99.33 Million USD |
| MoneyControl | $99.33 Million USD |
| MarketWatch | $99.33 Million USD |
| marketcap.company | $99.33 Million USD |
| Reuters | $99.33 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Themis Medicare Limited
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It provides active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic, anti-diabetic, a… Read more